Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
Repositioning or repurposing drugs account for a substantial part of entering approval pipeline drugs, which indicates that drug repositioning has huge market potential and value. Computational technologies such as machine learning methods have accelerated the process of drug repositioning in the la...
Main Authors: | Sha Zhu, Qifeng Bai, Lanqing Li, Tingyang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022002136 |
Similar Items
-
Changing Trends in Computational Drug Repositioning
by: Jaswanth K. Yella, et al.
Published: (2018-06-01) -
Drug Repositioning for Hand, Foot, and Mouth Disease
by: Ran Yan, et al.
Published: (2022-12-01) -
Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01) -
Computational Drug Repositioning: Current Progress and Challenges
by: Younhee Ko
Published: (2020-07-01) -
Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01)